Castleview Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,089
Closed -$354K 236
2026
Q1
$354K Buy
4,089
+1,738
+74% +$166K 0.18% 126
2025
Q4
$226K Buy
2,351
+24
+1% +$2.33K 0.11% 176
2025
Q3
$222K Buy
+2,327
New +$214K 0.12% 161
2025
Q1
Sell
-506
Closed -$40.6K 410
2024
Q4
$40.6K Sell
506
-4
-0.8% -$346 0.02% 368
2024
Q3
$45.9K Sell
510
-137
-21% -$11.5K 0.03% 332
2024
Q2
$50.9K Buy
647
+18
+3% +$1.48K 0.03% 331
2024
Q1
$54.8K Sell
629
-112
-15% -$9.56K 0.03% 340
2023
Q4
$61K Buy
741
+174
+31% +$13.3K 0.04% 271
2023
Q3
$44.4K Sell
567
-224
-28% -$18.8K 0.04% 268
2023
Q2
$69.7K Sell
791
-16
-2% -$1.38K 0.06% 221
2023
Q1
$65.1K Buy
807
+59
+8% +$4.81K 0.06% 231
2022
Q4
$58.1K Buy
748
+79
+12% +$6.4K 0.06% 221
2022
Q3
$54K Sell
669
-954
-59% -$85.7K 0.05% 246
2022
Q2
$146K Buy
+1,623
New +$164K 0.12% 176
2022
Q1
Sell
-452,593
Closed -$4.38K 893
2021
Q4
$4.38K Buy
+452,593
New +$52.4M 0.03% 176
2021
Q2
$280K Buy
+2,253
New +$283K 0.12% 177

Other funds holding MDT

Castleview Partners's MDT Position: Q2 2026 in Review

Castleview Partners sold out of Medtronic (MDT) in Q2 2026, closing a stake of 4,089 shares — an estimated $354K sold.

Castleview Partners first reported a position in MDT in Q2 2021 and held it in 16 quarters. The position peaked at $354K in Q1 2026. 451 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Castleview Partners reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Castleview Partners sold 4,089 Medtronic shares in Q2 2026, an estimated $354K.
  • Castleview Partners first reported a position in Medtronic in Q2 2021 and held it in 16 quarters.
  • Castleview Partners's Medtronic position peaked at $354K in Q1 2026.
  • 451 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.